These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26301748)

  • 41. 'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa.
    Moodley N; Saimen A; Zakhura N; Motau D; Setswe G; Charalambous S; Chetty-Makkan CM
    BMC Public Health; 2020 Apr; 20(1):454. PubMed ID: 32252703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment.
    Makabayi-Mugabe R; Musaazi J; Zawedde-Muyanja S; Kizito E; Namwanje H; Aleu P; Charlet D; Freitas Lopez DB; Brightman H; Turyahabwe S; Nkolo A
    BMC Health Serv Res; 2022 Feb; 22(1):154. PubMed ID: 35123467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
    Jakasania A; Shringarpure K; Kapadia D; Sharma R; Mehta K; Prajapati A; Kathirvel S
    BMC Infect Dis; 2020 Dec; 20(1):918. PubMed ID: 33267826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nurses as providers of emotional support to patients with MDR-TB.
    Chalco K; Wu DY; Mestanza L; Muñoz M; Llaro K; Guerra D; Palacios E; Furin J; Shin S; Sapag R
    Int Nurs Rev; 2006 Dec; 53(4):253-60. PubMed ID: 17083413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up.
    Yu MC; Chiang CY; Lee JJ; Chien ST; Lin CJ; Lee SW; Lin CB; Yang WT; Wu YH; Huang YW
    Clin Infect Dis; 2018 Jul; 67(2):202-210. PubMed ID: 29394358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Gradmann C; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e035272. PubMed ID: 32554739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
    Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
    Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
    Singla N; Singla R; Jain G; Habib L; Behera D
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient's perspective.
    Appiah MA; Arthur JA; Gborgblorvor D; Asampong E; Kye-Duodu G; Kamau EM; Dako-Gyeke P
    BMC Public Health; 2023 Jul; 23(1):1317. PubMed ID: 37430295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    Gualano G; Mencarini P; Musso M; Mosti S; Santangelo L; Murachelli S; Cannas A; Di Caro A; Navarra A; Goletti D; Girardi E; Palmieri F
    PLoS One; 2019; 14(2):e0212948. PubMed ID: 30817779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient satisfaction with directly observed treatment and multidrug-resistant tuberculosis injection administration by lay health workers in rural Eswatini.
    Peresu E; Heunis CJ; Kigozi GN; De Grave D
    Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e10. PubMed ID: 32501027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam.
    Hoa NB; Nhung NV; Khanh PH; Hai NV; Quyen BT
    BMC Res Notes; 2015 Dec; 8():809. PubMed ID: 26695761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study.
    Gebreweld FH; Kifle MM; Gebremicheal FE; Simel LL; Gezae MM; Ghebreyesus SS; Mengsteab YT; Wahd NG
    J Health Popul Nutr; 2018 Jan; 37(1):1. PubMed ID: 29304840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania.
    Sariah A; Rugemalila J; Protas J; Aris E; Siril H; Tarimo E; Urassa D
    BMC Public Health; 2019 Aug; 19(1):1172. PubMed ID: 31455306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.